100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Concise summary of the Nervous System £7.48   Add to cart

Summary

Concise summary of the Nervous System

2 reviews
 79 views  1 purchase

A detailed summary of the Nervous System

Preview 3 out of 16  pages

  • No
  • Chapter 4 - nervous system
  • November 4, 2020
  • 16
  • 2019/2020
  • Summary
book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:
All documents for this subject (27)

2  reviews

review-writer-avatar

By: rubana8 • 2 year ago

review-writer-avatar

By: ayodeledelrah • 2 year ago

avatar-seller
anmoll
Chapter 4 – The Nervous System



 CHM/MHRA – increased risk of stroke and
Chapter 4 – The death when APs are used in elderly with
Nervous System dementia. Hence, consider risks like H/O
stroke or TIA, HT, DM, smoking and AF
 Use at lowest effective dose for shortest
DEMENTIA
time possible (review every 6 weeks)
 Define – progressive syndrome  In non-Alzheimer’s dementia, APs can
characterised by memory loss, problems worsen motor functions
with reasoning and communication, change 2. Depression and anxiety – CBT or relaxation.
in personality and reduced ability to carry Use ADs for severe problems
out daily activities. 3. Sleep disturbances – sleep hygiene, daylight
 Causes = Alzheimer’s (most common type), exposure and increase exercise
vascular dementia (due to cerebrovascular
disease), dementia with Lewy bodies, mixed
EPILEPSY
dementia and frontotemporal dementia Choosing AED – consider epilepsy syndrome,
 Tx aims = promote independence, maintain seizure type, other meds, co-morbidity, age, sex
function and manage symptoms
AEDs with a long t½ (ON dose) = lamotrigine,
Treatment Options phenytoin, perampanel, phenobarbital
Mild-to-mod dementia presenting with CAT 1 - maintain on specific brand or generic
cognitive symptoms = structured group  CZP, phenobarbital, phenytoin, primidone
cognitive stimulation, group reminiscence
therapy, cognitive rehab, occupational therapy CAT 2 - based on clinical judgement, meeting
with Pt, seizure frequency, Tx history
Cognitive symptoms (Alzheimer’s):  Clobazam, clonazepam, eslicarbazepine,
1. 1st line in mild-to-mod Alzheimer’s = lamotrigine, oxcarbazepine, perampanel,
donepezil, galantamine or rivastigmine rufinamide, topiramate, valproate,
2. If anticholinesterases are not tolerated = zonisamide
memantine (preferred in mod-severe AD)
 Minimise use of anti-muscarinics CAT 3 - no need to maintain specific product
(antidepressants, antihistamines,  Brivaracetam, ethosuximide, gabapentin,
antipsychotics and urinary antispasmodics) lacosamide, levetiracetam, pregabalin,
to reduce cognitive impairment tiagabine, vigabatrin
 Avoid stopping acetylcholinesterases (based Antiepileptic Hypersensitivity Syndrome –
on disease severity alone) due to risk of associated with CZP, lacosamide, lamotrigine,
substantial worsening of cognitive function oxcarbazepine, phenobarbital, phenytoin,
Non-Alzheimer’s dementia: primidone, rufinamide (lower risk with
1. Dementia with Lewy bodies, vascular eslicarbazepine, stiripentol, zonisamide)
dementia, Parkinson’s disease dementia  Symptoms start between 1-8 weeks of
= donepezil (1st line), galantamine, exposure; fever, rash, lymphadenopathy,
rivastigmine or memantine (2nd line) multi-organ failure, liver dysfunction,
Non-cognitive symptoms: vasculitis, haematological, renal and
1. Agitation, aggression, distress or psychosis – pulmonary abnormalities
also offer APs if Pt is at risk of harm  Withdraw ASAP and do not re-expose

,Chapter 4 – The Nervous System


Risk of suicidal thoughts – seek advice if Pt  Folate supplements are advised, before
develops mood changes, distress, etc conception and during 1st trimester, to
reduce risk of neural tube defects
Withdrawal – avoid abruptly due to risk of
 Adjust doses of phenytoin, CZP and
severe, rebound seizures. If receiving multiple
lamotrigine based on [plasma-drug]
AEDs, withdraw one drug at a time
 Monitor foetal growth in Pts taking
Driving – if a seizure occurs, stop driving ASAP levetiracetam and topiramate
and inform DVLA.  Women who have seizures in the 2nd half of
 Avoid driving for 6 months after Pt has their the pregnancy should be assessed for
1st unprovoked epileptic seizure or a single eclampsia before changing AED Tx
isolated seizure.  Routine injection of vitamin K at birth
 To continue driving, Pt must be seizure-free reduces risk of neonatal haemorrhage
for at least 1 year, have a pattern of seizures  BZPs and phenobarbital are likely to cause
where there’s no influence on their withdrawal effects in newborn
consciousness or ability to act and not have  All pregnant women with epilepsy
a H/O unprovoked seizures (regardless of whether they’re taking AEDs)
 Pts who’ve had a seizure while asleep are should notify the UK Epilepsy and
not allowed to drive for 1 year from the Pregnancy Register
date of each seizure unless;
Breast-feeding
1. a history or pattern of sleep seizures
 If taking 1 AED, encourage BF. If taking >1 or
occurring only ever while asleep has
as a premature birth, seek specialist advice
been proven over at least 1 year from
 Monitor all infants for sedation, feeding
the date of 1st sleep seizure; or
difficulties, adequate weight gain, ADRs
2. a proven pattern of only asleep seizures
from AEDs and developmental milestones
is proven over 3 years if Pt has H/O
 If toxicity occurs, start formula feeds wean
seizures whilst awake (+/- asleep)
infant off breast-milk to reduce exposure
 Avoid driving during AED changes or
withdrawal and for 6 months after last dose AEDs readily
Ethosuximide, Lamotrigine,
 If seizure occurs due to AED change or transferred
Primidone, Zonisamide
withdrawal, revoke license for 1 year; into breast-milk
consider re-licensing earlier if Tx has been Lamotrigine
AEDs that accumulate due to
reinstated for 6 months and no further Phenobarbita
slow metabolism in infant
seizures have occurred l
BZPs
Pregnancy AEDs linked with drowsiness Primidone
 Valproate has the highest risk of serious in infants Phenobarbita
developmental disorders (30-40% risk) and l
congenital malformations (10% risk) Lamotrigine
AEDs likely to cause
 Other drugs with teratogenicity risk = Phenobarbita
withdrawal effects in infant
phenytoin, primidone, lamotrigine, CZP l
due to sudden cessation
 Topiramate – increased risk of congenital Primidone
malformations (incl. cleft palate, Treatment Options
hypospadias) if taken in 1st trimester
 Risk of harm to mother and foetus from Focal seizures (+/- 2° generalisation)
convulsive seizures > continued therapy 1. Carbamazepine or lamotrigine
 Avoid stopping Tx due to risk to foetus

, Chapter 4 – The Nervous System


2. Levetiracetam, oxcarbamazepine, valproate 3. IV lorazepam – if seizure lasts >5 mins.
Repeat once after 10mins if seizures recur
3. CZP, clobazam, gabapentin, lamotrigine, 4. IV diazepam – risk of thrombophlebitis
levetiracetam, oxcarbamazepine, valproate, 5. Rectal diazepam or midazolam oromucosal
topiramate solution – where facilities for resuscitation
Tonic-clonic seizures are not immediately available
1. Valproate or lamotrigine 6. If, after Tx with BZPs, seizure recur or fail to
2. CZP, oxcarbamazepine respond 25mins after onset – phenytoin
3. Clobazam, levetiracetam, topiramate (slow IV injection) or phenobarbital
7. If (6) fails to control seizures 45mins after
Absence seizures onset – anaesthesia with thiopental,
1. Ethosuximide or valproate midazolam or propofol
2. Lamotrigine
3. Clobazam, clonazepam, levetiracetam, Febrile convulsions = anti-pyretic
topiramate, zonisamide Prolonged febrile convulsions (>5mins) or
4. AVOID CZP, gabapentin, oxcarbazepine, recurrent febrile convulsions = treat actively
phenytoin, pregabalin, tiagabine, vigabatrin
ATTENTION DEFICIT HYPERACTIVITY
Myoclonic seizures
DISORDER (ADHD)
1. Valproate
2. Topiramate or levetiracetam  Define – behavioural disorder characterised
3. Clobazam, clonazepam, zonisamide by hyperactivity, impulsivity and inattention
4. AVOID CZP, gabapentin, oxcarbazepine, leading to functional impairment.
phenytoin, pregabalin, tiagabine, vigabatrin  Symptoms usually occur in ages 3-7 years
but may not be recognised till >7 years
Generalised tonic-clonic seizures that co-exist
 More common in males
with myoclonic seizures in idiopathic epilepsy
 Inattentive symptoms usually persist unlike
1. Valproate or levetiracetam
hyperactive-impulsive symptoms
Atonic and tonic seizures  Associated with oppositional defiant
1. Valproate or lamotrigine disorder (ODD), conduct disorder and mood
2. Rufinamide or topiramate disorders like anxiety, mania, depression
3. AVOID CZP, gabapentin, oxcarbazepine, and substance misuse
pregabalin, tiagabine, vigabatrin  Tx aims = reduce functional impairment and
symptoms and improve quality of life
Dravet syndrome = valproate or topiramate
Non-drug Tx = balanced diet, good nutrition
Lennox-Gastaut syndrome = valproate or
and regular exercise.
lamotrigine
 Other options include environmental
Epilepsy associated with menstruation =
changes to lighting, noise, reducing
acetazolamide
distractions and reinforcing verbal requests
Status epilepticus with written instructions.
 Position Pt to avoid injury  CBT is effective in Pts refusing drug Tx, etc
 Support respiration by providing oxygen
Drug Tx
 Maintain BP and correct hypoglycaemia
1. Methylphenidate or lisdexamfetamine
1. IV thiamine – if alcohol abuse suspected
2. If no improvement within 6 weeks – switch
2. Pyridoxine – if caused by low pyridoxine
to the alternative 1st line drug

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller anmoll. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for £7.48. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

62890 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy revision notes and other study material for 14 years now

Start selling
£7.48  1x  sold
  • (2)
  Add to cart